Compare Diagnos Laboratorium Utama Tbk. (DGNS) vs RDI Insight ETF FTSE Indonesia Low Volatility Factor Index (XILV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Diagnos Laboratorium Utama Tbk. vs RDI Insight ETF FTSE Indonesia Low Volatility Factor Index — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while RDI Insight ETF FTSE Indonesia Low Volatility Factor Index trades at Rp118 (market cap 2.74B, 41.4K 24h volume). The key difference: Diagnos Laboratorium Utama Tbk. is far larger — about 113.4× RDI Insight ETF FTSE Indonesia Low Volatility Factor Index's market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 41.4K). Which is the better fit depends on your goals.
| DGNS | XILV | |
|---|---|---|
Market Cap | 310.75B | 2.74B |
Volume | 963.6K | 41.4K |
Lot | 9.64K | 414 |
Turnover | 217.67M | 4.9M |
Average Price | 225.89 | 118.3 |
Value | 217.67M | 4.9M |
Indicative Equilibrium Price | 226 | — |
Indicative Equilibrium Volume | 1K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Diagnos Laboratorium Utama Tbk.
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →
